Target intelligence / Profile preview

PR domain zinc finger protein 4 messenger RNA 3'-untranslated region (PRDM4 mRNA 3'-UTR)

Target
PRDM4 mRNA 3'-UTR
Molecular classification
RNA, Regulatory element, Other
01

Overview

The PRDM4 mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the messenger RNA encoding the PR domain zinc finger protein 4 (PRDM4), also known as SC1 or PFM1 (UniProt Q9UKN5). This region contains specific sequences that serve as binding sites for microRNAs (miRNAs) and RNA-binding proteins, which govern the stability and translation efficiency of the PRDM4 transcript (PLoS One 2013, 8(8):e72149). PRDM4 itself functions as a transcription factor and epigenetic modifier, playing vital roles in neural stem cell maintenance, cell cycle regulation, and tumor suppression by interacting with partners like PRMT5 and HDACs (J Biol Chem 2012, 287(51):42995-43006). Dysregulation of the PRDM4 3'-UTR, such as through the binding of oncogenic miRNAs like miR-373 or the loss of tumor-suppressive miRNAs like miR-16, can lead to aberrant PRDM4 protein levels (Oncogene 2021, 40(18):3318-3330). This dysregulation is linked to the progression of various cancers, including cervical and gastric malignancies, where PRDM4 often acts as a tumor suppressor (Oncogene 2021, 40(18):3318-3330). While no small molecule drugs currently target this specific RNA region, it represents a promising site for the development of RNA-based therapeutics, such as antisense oligonucleotides or miRNA mimics, designed to precisely modulate PRDM4 expression. Targeting the 3'-UTR offers a mechanism to restore protein levels in contexts where PRDM4 is silenced, providing a novel avenue for cancer and neurodevelopmental therapies.

Other names
PRDM4 3'-UTRPFM1 mRNA 3'-UTRSC1 mRNA 3'-UTRPR domain-containing protein 4 3'-untranslated region
02

Mechanism of action

Post-transcriptional regulation of PRDM4 protein levels through microRNA-mediated mRNA degradation or translational inhibition.

03

Biological functions

Post-transcriptional regulationmRNA stabilityTranslation regulationCell cycle regulationCell differentiation
04

Disease associations

CancerNeurodevelopmental disordersGastric cancerCervical cancer
05

Safety considerations

Off-target effects of RNA-based therapeuticsDelivery challenges to target tissuesPotential for systemic toxicity with microRNA mimics
06

Biomarkers

PRDM4 expression levelsmiR-16 levelsmiR-373 levels

Beyond the preview

Go deeper on PR domain zinc finger protein 4 messenger RNA 3'-untranslated region (PRDM4 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PR domain zinc finger protein 4 messenger RNA 3'-untranslated region (PRDM4 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call